老年I期非小细胞肺癌:VATS肺叶切除与SBRT的总生存比较
本研究比较65岁及以上临床I期NSCLC患者接受VATS肺叶切除或SBRT的总生存,纳入2010–2015年792例患者,采用倾向评分匹配分析。匹配后VATS组中位OS为77个月、SBRT组为33个月,5年OS率分别为58%与29%(p<0.001),提示能耐受手术的老年患者VATS肺叶切除生存更优。
要点
- 匹配后VATS肺叶切除中位OS 77个月,SBRT为33个月。
- 匹配后5年OS率VATS 58%,SBRT 29%(p<0.001)。
- 能耐受手术的老年I期NSCLC患者可优先考虑VATS肺叶切除。
核心结论
- 老年I期NSCLC患者接受VATS肺叶切除的总生存优于SBRT,且不受匹配影响。
- 该结果对能耐受手术的老年患者临床决策可能具有重要价值。
研究设计与样本
- 回顾性比较研究,纳入2010–2015年792例年龄≥65岁的临床I期NSCLC患者。
- 主要分析为全队列倾向评分匹配,次要分析为有肺功能数据亚组。
主要发现
- 未匹配患者VATS组中位OS 77个月,SBRT组38个月。
- 未匹配1、3、5年OS率VATS为92%、76%、65%,SBRT为90%、52%、29%(p<0.001)。
- 匹配后VATS组中位OS 77个月,SBRT组33个月。
- 匹配后1、3、5年OS率VATS为91%、68%、58%,SBRT为87%、46%、29%(p<0.001)。
- 次要分析调整未匹配变量后,VATS肺叶切除的生存优势仍存在(p=0.034)。
临床怎么用
- 对能耐受手术的老年临床I期NSCLC患者,VATS肺叶切除可作为优先考虑的生存获益选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Comparative studies of the overall survival (OS) in elderly patients with nonsmall cell lung cancer (NSCLC) after surgery or stereotactic body radiotherapy (SBRT) have been limited by mixed extents of resection and different surgical approaches.792 patients aged ≥65 years with clinical stage I NSCLC underwent video-assisted thoracic surgery (VATS) lobectomy or SBRT between 2010 and 2015. The propensity score-matched primary analysis included data from the full cohort; the secondary analysis included data from a subgroup of patients with data on pulmonary function.Median OS for unmatched patients was 77 months for patients undergoing VATS lobectomy and 38 months for SBRT. The 1-, 3- and 5-year OS rates after VATS lobectomy were 92%, 76% and 65%, and after SBRT were 90%, 52% and 29% (p<0.001). Median OS for matched patients in the primary analysis was 77 months for patients undergoing VATS lobectomy and 33 months for SBRT. The 1-, 3- and 5-year OS rates after VATS lobectomy were 91%, 68% and 58%, and after SBRT were 87%, 46% and 29% (p<0.001). The survival advantage with VATS lobectomy persisted in the secondary analysis after adjusting for non-matched variables (p=0.034).We suggest that elderly patients with stage I NSCLC undergoing VATS lobectomy have a better rate of OS than patients undergoing SBRT, irrespective of matching. This could be clinically important in decision-making for elderly patients who can tolerate surgery.
引用
- Detillon DDEMA, Aarts MJ, De Jaeger K, et al. Video-assisted thoracic lobectomy versus stereotactic body radiotherapy for stage I nonsmall cell lung cancer in elderly patients: a propensity matched comparative analysis. Eur Respir J. 2019. PMID: 30923188. doi:10.1183/13993003.01561-2018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。